Alpha Capital Anstalt v. BriaCell Therapeutics Corp.: Complaint

Complaint in Alpha Capital Anstalt, of Liechtenstein v. BriaCell Therapeutics Corp., a Canadian company that “describes itself as “clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer” and whose shares are listed on NASDAQ and the Toronto Stock Exchange, at the Supreme Court of the State of New York, County of New York.

- You’re only seeing part of this content
  
  To view the entire article or download the document, subscribe today.
  
  – Offshore Courts: 29,000+ court cases (Bahamas, Bermuda, BVI, Cayman Islands)
  – Investigative Articles: 4,500+ in-depth articles, including fraud exposés
  – MLATs – Criminal: 1,400+ MLATs on global criminal investigations
  – Ch. 15 – Insolvencies: Monitored daily
  – Foreign Discovery: Applications for foreign discovery filed in the USA, monitored daily
  – Regulatory Actions: Global regulatory actions, fines, and bans, monitored daily
  – And More: Criminal indictments, extraditions, winding-up petitions, and more
  
  Unlimited access for less than $3/day.
  
  Cancel anytime.
  
  SUBSCRIBE
- SIGN IN
  
  Forgot your password?

Pages: 9

Date: May 19, 2021

Defendants/Respondents: BriaCell Therapeutics Corp.

Plaintiffs/Applicants Attorneys: Hoffner PLLC, David Hoffner

Case Number: Xx Xx Xx

Topic: Investment, Listed Securities

Plaintiffs/Applicants: Alpha Capital Anstalt

Topics

Keywords

Alpha Capital Anstalt BriaCell Therapeutics Corp.

BECOME A SUBSCRIBER

Daily red flags in high-value international finance

Unlimited access. No contracts. Cancel anytime.